Economic Analysis of Seasonal Influenza Inactive Vaccine Injection in Pregnant Women of Iran
Publish place: 21th International Congress of Microbiology of Iran
Publish Year: 1399
نوع سند: مقاله کنفرانسی
زبان: English
View: 317
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MEDISM21_179
تاریخ نمایه سازی: 23 مرداد 1400
Abstract:
Background and Aim : Pregnant women are considered as one of the high-risk groups for influenza. The best way to protect influenza in pregnant women and infants less than ۶ months of age is to vaccinate pregnant women. Given the importance of vaccination against seasonal influenza in pregnant women and the cost of preventing influenza in pregnant women, can vaccination in pregnant women be considered as a cost-effective intervention?Methods : The present economic evaluation study was conducted from a social perspective. The decision tree model was used for economic analysis of influenza vaccine injection in pregnant women compared with no vaccine in the same control group. Clinical efficacy and side effects of the vaccine were obtained using a systematic review study. In order to calculate the costs of treatment of patients or other unintended consequences of the disease, the records of patients admitted to Imam Reza Hospital in Tabriz were studied. Cost-effectiveness ratios were compared with cost-effectiveness thresholds to decide on vaccine effectiveness. One-way sensitivity analysis was used to investigate the effect of uncertainty on decision making.Results : The efficacy rate of the influenza vaccine in reducing laboratory-confirmed cases of influenza was ۴۷ %( ۰.۲۲-۰.۶۴) by a meta-analysis of international studies. Vaccination of pregnant women against non-vaccination had incremental cost-effectiveness (ICER) of ۱۴۲۹۲۶۷۱ Rials per QALY. The results of the study were not sensitive to key changes.Conclusion : Influenza vaccination in pregnant women reduces laboratory-confirmed influenza in them and infants under ۶ months of age who are not eligible for influenza vaccine. This is a cost-effectiveness intervention.
Keywords:
Authors
Zakieh Ostadahmadi
Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
Alireza Mahboub-Ahari
Tabriz Health services management research center, Faculty of management and medical informatics, Tabriz University of Medical Sciences, Tabriz, Iran